13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q2 2019. See the latest, Q2 2026 →
Reported value
$314.99B
−0.1% on the quarter before
Positions
401
31 new · 45 sold out
Top 10
27.6%
of the value
Est. gain
+$6.77B
on stocks held all quarter
Est. return
+2.4%
on those stocks since Q1 2019
Positions as of Jun 30, 2019, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 45% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2019. Striped tiles are options.
Largest buys
Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Tc Energy Corp~$1.49BNew · 0.0% → 0.5%+30,064,463 shares
- Constellation Brands Inc Cl A~$1.48BAdded · 0.1% → 0.6%+7,519,244 shares
- Broadcom~$1.35BAdded · 2.1% → 2.5%+4,707,106 shares
- Alcon Inc~$1.28BNew · 0.0% → 0.4%+20,711,438 shares
- Unitedhealth Group Inc~$1.03BAdded · 1.4% → 1.7%+4,229,363 shares
- Keurig Dr Pepper Inc~$822.0MAdded · 0.1% → 0.4%+28,444,038 shares
- L3harris Technologies Inc~$788.1MNew · 0.0% → 0.3%+4,166,851 shares
- Humana Inc~$695.0MAdded · 0.4% → 0.6%+2,619,743 shares
- 3m Company~$676.7MAdded · 0.2% → 0.4%+3,904,081 shares
- Netflix~$632.0MAdded · 3.0% → 3.3%+1,720,493 shares
Largest sells
Since Q1 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Abbvie Inc~$2.65BCut · 3.7% → 2.5%−36,384,326 shares
- Verizon Communications Inc~$1.88BCut · 1.3% → 0.7%−32,939,640 shares
- Booking Holdings Inc~$1.54BCut · 0.7% → 0.2%−820,148 shares
- Berkshire Hathaway Inc Cl B~$1.35BCut · 0.6% → 0.2%−6,344,929 shares
- Alphabet~$1.35BCut · 1.7% → 1.1%−1,249,606 shares
- Qualcomm~$1.21BCut · 0.5% → 0.3%−15,887,331 shares
- Philip Morris International~$1.05BCut · 1.4% → 0.9%−13,307,525 shares
- Alphabet~$882.3MCut · 1.6% → 1.2%−814,795 shares
- Amgen Inc~$707.0MCut · 2.0% → 1.7%−3,836,745 shares
- Harris Corp~$700.6MSold out · 0.2% → 0.0%−4,386,440 shares
Holdings
As of Jun 30, 2019. Changes are in shares against Mar 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MetaCOMMON STOCK · shares +1.6% · price +15.8% | 4.5% | $14.06B | +$1.89B | ||||||||
| MicrosoftCOMMON STOCK · shares −3.6% · price +13.6% | 4.0% | $12.63B | +$1.51B | ||||||||
| NetflixCOMMON STOCK · shares +6.5% · price +3.0% | 3.3% | $10.42B | +$286.7M | ||||||||
| Abbott LaboratoriesCOMMON STOCK · shares +1.1% · price +5.2% | 3.1% | $9.82B | +$480.8M | ||||||||
| Abbvie IncCOMMON STOCK · shares −25% · price −9.8% | 2.5% | $8.01B | −$866.7M | ||||||||
| BroadcomCOMMON STOCK · shares +21% · price −4.3% | 2.5% | $7.81B | −$288.1M | ||||||||
| AmazonCOMMON STOCK · shares −0.9% · price +6.3% | 2.5% | $7.77B | +$463.4M | ||||||||
| Gilead Sciences IncCOMMON STOCK · shares +4.6% · price +3.9% | 1.8% | $5.52B | +$199.4M | ||||||||
| Amgen IncCOMMON STOCK · shares −11% · price −3.0% | 1.7% | $5.45B | −$168.5M | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares +24% · price −1.3% | 1.7% | $5.39B | −$58.1M | ||||||||
| AlibabaCOMMON STOCK · shares +8.3% · price −7.1% | 1.6% | $5.13B | −$363.3M | ||||||||
| Exxon Mobil CorpCOMMON STOCK · shares −2.0% · price −5.2% | 1.5% | $4.69B | −$255.2M | ||||||||
| MastercardCOMMON STOCK · shares +1.5% · price +12.4% | 1.5% | $4.65B | +$504.2M | ||||||||
| General Dynamics CorpCOMMON STOCK · shares +6.6% · price +7.4% | 1.4% | $4.48B | +$289.7M | ||||||||
| Eog Resources IncCOMMON STOCK · shares +2.4% · price −2.1% | 1.4% | $4.45B | −$94.2M | ||||||||
| IntelCOMMON STOCK · shares −11% · price −10.9% | 1.3% | $4.20B | −$511.2M | ||||||||
| AlphabetCOMMON STOCK · shares −19% · price −8.0% | 1.2% | $3.87B | −$335.9M | ||||||||
| Thermo Fisher Scientific IncCOMMON STOCK · shares −12% · price +7.3% | 1.2% | $3.78B | +$256.7M | ||||||||
| AlphabetCOMMON STOCK · shares −27% · price −7.9% | 1.1% | $3.58B | −$306.2M | ||||||||
| Csx CorpCOMMON STOCK · shares +4.4% · price +3.4% | 1.1% | $3.51B | +$110.7M | ||||||||
| Home Depot IncCOMMON STOCK · shares +3.5% · price +8.4% | 1.1% | $3.49B | +$260.5M | ||||||||
| Linde PlcCOMMON STOCK · shares +7.4% · price +14.2% | 1.0% | $3.25B | +$375.8M | ||||||||
| Coca-Cola CoCOMMON STOCK · shares −7.1% · price +8.7% | 1.0% | $3.15B | +$251.4M | ||||||||
| Nike Inc Cl BCOMMON STOCK · shares −10% · price −0.3% | 0.99% | $3.13B | −$9.7M | ||||||||
| Accenture Plc Cl ACOMMON STOCK · shares −5.7% · price +5.0% | 0.98% | $3.09B | +$146.2M | ||||||||
| Total · 401 positions | 100% | $314.99B | +$6.77B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2019 to Q2 2019: 363 stocks held throughout, up $6.77B (+2.4%).
- Meta+$1.89B+16%
- Microsoft+$1.51B+14%
- Mastercard+$504.2M+12%
- Abbott Laboratories+$480.8M+5%
- Amazon+$463.4M+6%
- Philip Morris International−$370.2M−11%
- Intel−$511.2M−11%
- Altria Group Inc−$612.1M−18%
- Teva Pharmaceutical Industries Ltd ADR−$826.8M−41%
- Abbvie Inc−$866.7M−10%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |